24_8_2016.pdfE. G. H. K. F No 12-22/2016-DC CT NOC No: CT/SND/35/2016 Rivastigmine transdermal patch...
2
24_8_2016.pdfE. G. H. K. F No 12-22/2016-DC CT NOC No: CT/SND/35/2016 Rivastigmine transdermal patch Any report of serious adverse event occurring during clinical trial study to the
